JENNIFER WIT: Open Payments
NPI 1104925718 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 30 payments from 13 companies in 2025. Trend: 2023 $1,022 · 2024 $698 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $194 |
| Novo Nordisk Inc | 5 | $174 |
| ABBVIE INC. | 3 | $76 |
| Kowa Pharmaceuticals America, Inc. | 4 | $67 |
| PFIZER INC. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Amgen Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Ozempic, BREZTRI, QULIPTA, ZORYVE, AIRSUPRA, XIFAXAN, NURTEC ODT, OTEZLA.
Industry payments across FL — which companies pay providers there.
